BioSpace News Archive

The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19. Scientists from the two organizations have generated and characterized SARS-CoV-2 virus-like particles (

RSI-MRI+ for Prostate will be integrated across SimonMed’s U.S. imaging network for improved prostate cancer detection using AI-powered post-processing software. SCOTTSDALE, Ariz. & SAN DIEGO--( BUSINESS WIRE )-- SimonMed Imaging has reached an agreement with CorTechs Labs to onboard RSI-MRI+ for Prostate across many of its North American imaging sites. This press release features multimedia. View the full release here: https://www.business

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, held a virtual ground-breaking ceremony on August 19, 2020 to signal the start of its Advanced Therapies Innovation Center construction project.

Arena Pharmaceuticals, Inc. announced that on August 15, 2020, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to purchase an aggregate of 15,275 shares of its common stock and 3,440 inducement restricted stock units.

CooperCompanies, will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 2020.

Medical Group Management Association (MGMA) has designed this year’s Medical Practice Excellence Conference (MPEC20) to provide medical practices across the United States with critical, actionable guidance about how to navigate the significant challenges that medical practices are facing today.

First and Only Technology Providing Continuous Real-Time Alerting of Heart Attacks

Mopec—a leading provider of high-quality pathology, anatomy, mortuary, and necropsy equipment and products—announced the release of their Safe View body bag, designed specifically for COVID-19 crisis response.

Presentation to include recent and upcoming developments and overview of drug candidate JAN101 for the potential treatment of peripheral artery disease (PAD) as well as potential applications for COVID-19 vascular complications and planned IND submission process with FDA [19-August-2020] LAS VEGAS , Aug. 19, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company fo

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER 2 study results have been published in the latest edition of the American Heart Association’s journal, Stroke